Scarica l'app Stockscreener
2.60
3.70%
-0.10
Pre-mercato:
2.60
Precedente Chiudi:
$2.70
Aprire:
$2.7
Volume 24 ore:
44,036
Relative Volume:
0.52
Capitalizzazione di mercato:
$10.36M
Reddito:
$125.00K
Utile/perdita netta:
$-14.50M
Rapporto P/E:
-0.5647
EPS:
-4.6043
Flusso di cassa netto:
$-14.18M
1 W Prestazione:
-4.06%
1M Prestazione:
-12.16%
6M Prestazione:
-37.50%
1 anno Prestazione:
-75.08%
Intervallo 1D:
$2.50
$2.70
Intervallo di 1 settimana:
$2.50
$2.82
Portata 52W:
$2.50
$41.22
Imunon Inc Stock (IMNN) Company Profile
Nome
Imunon Inc
Settore
Industria
Telefono
(609) 896-9100
Indirizzo
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
2.60 | 10.76M | 125.00K | -14.50M | -14.18M | -4.6043 |
VRTX
Vertex Pharmaceuticals Inc
|
453.06 | 113.78B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
719.88 | 75.84B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
802.70 | 50.55B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.48 | 38.99B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
316.55 | 32.69B | 5.76B | 514.49M | 1.10B | 4.4813 |
Imunon Inc Borsa (IMNN) Ultime notizie
Imunon (IMNN) Declines -3.00% Amid Market Weakness 2026-05-13Crowd Consensus Signals - newser.com
Imunon | 10-Q: Q1 2026 Earnings Report - Moomoo
Imunon, Inc. (NASDAQ:IMNN) Q1 2026 Earnings Call Transcript - Insider Monkey
Imunon Q1 2026 Earnings Preview - MSN
IMNN: IMUNON Progresses in Clinical Trials with Strong Financial Management - GuruFocus
Imunon’s Earnings Call Balances Survival Gains and Risks - TipRanks
Imunon Inc (IMNN) Q1 2026 Earnings Call Highlights: Promising Clinical Progress Amidst Funding ... By GuruFocus - Investing.com Canada
Imunon Inc (IMNN) Q1 2026 Earnings Call Highlights: Promising Cl - GuruFocus
IMNN's Enrollment in Phase 3 Trial Exceeds Expectations - GuruFocus
IMUNON, INC. Q1 2026 SEC 10-Q Filing: Financial Statements, Risk Factors, and Management Discussion - Minichart
How Should Investors Value Imunon (IMNN) After Q1 2026 Earnings? - GuruFocus
IMUNON Reports Promising Phase 2 Survival Data and Advances Phase 3 OVATION 3 Trial for Ovarian Cancer in Q1 2026 Financial Results Update - Minichart
Earnings call transcript: Imunon Q1 2026 highlights clinical trial progress - Investing.com
IMNN: OVATION 3 enrollment outpaces forecasts as IMNN-001 shows strong survival benefit in ovarian cancer - TradingView
Imunon (IMNN) Q1 2026 Earnings Transcript - AOL.com
Earnings call transcript: Imunon Q1 2026 highlights clinical trial progress By Investing.com - Investing.com Canada
Imunon Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Imunon: FDA Has Reviewed and Is Aligned With Phase 3 Protocol, Confirms Path to BLA Filing - Moomoo
Imunon Releases Q1 2026 Financial Results - AlphaStreet
[10-Q] Imunon, Inc. Quarterly Earnings Report - Stock Titan
Imunon, Inc. 1Q 2026: Net loss $(4.25M), EPS $(0.84) — 10-Q Summary - TradingView
IMUNON ($IMNN) Releases Q1 2026 Earnings - Quiver Quantitative
Imunon Q1 net loss widens as R&D spending rises - TradingView
IMUNON (NASDAQ: IMNN) posts Q1 2026 loss while IMNN-001 shows strong survival data - Stock Titan
Imunon, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Imunon (IMNN.US) is scheduled to release its earnings report before the market opens on May 12. - Moomoo
Number of shareholders of Imunon, Inc. – NASDAQ:IMNN - TradingView
MSN Money - MSN
May 12 webcast to cover IMUNON's Q1 results, Phase 3 ovarian cancer update - Stock Titan
IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026 - Yahoo Finance
Imunon to discuss Q1 2026 financials and Phase 3 trial progress for ovarian cancer immunotherapy on May 12. - Pluang
[ARS] Imunon, Inc. SEC Filing - Stock Titan
Imunon, Inc. Files Form 8-K Announcing Change in Control Severance Agreement – Key Details and Company Information - Minichart
Imunon Adopts Change-of-Control Severance Agreements for Executives - TipRanks
Imunon (NASDAQ: IMNN) approves new change-in-control severance for execs - Stock Titan
Imunon (NASDAQ: IMNN) details 2026 virtual meeting, pay and plan votes - Stock Titan
IMNN Stock Price, Quote & Chart | IMUNON INC (NASDAQ:IMNN) - ChartMill
IMUNON launches up to $9.75M securities offering - MSN
Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026 - MSN
Maxim Group initiates coverage of Imunon (IMNN) with buy recommendation - MSN
IMNN Imunon posts far wider Q4 2025 loss than consensus estimates with zero revenue and unchanged share performance.Trending Buy Opportunities - newser.com
Imunon, Inc. (NASDAQ:IMNN) Q4 2025 Earnings Call Transcript - MSN
Maxim Group Initiates Imunon(IMNN.US) With Buy Rating, Announces Target Price $10 - Moomoo
IMNN Initiated Coverage by Maxim Group -- Rating Set to Buy - GuruFocus
IMNN (Imunon Inc.) shares rise modestly despite posting a far wider than expected fourth quarter 2025 loss.Crowd Entry Points - newser.com
Is Imunon Inc stock a good pick for beginnersWeekly Trade Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Imunon Inc. (IMNN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Imunon (IMNN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Guidance Update: Can Imunon Inc reach all time highs this year2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
Institution Moves: Can Imunon Inc sustain earnings growth2026 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
Investment Review: Can Imunon Inc continue delivering strong returns2026 Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Imunon Inc Azioni (IMNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.58%
3.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):